Endo International PLC Stock Rating Reaffirmed by Cantor Fitzgerald (ENDP)
Endo International PLC (NASDAQ:ENDP)‘s stock had its “sell” rating restated by Cantor Fitzgerald in a research note issued on Wednesday. They currently have a $52.00 price target on the stock, up from their previous price target of $37.00. Cantor Fitzgerald’s price target would suggest a potential downside of 23.25% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank initiated coverage on shares of Endo International PLC in a research note on Tuesday, July 22nd. They set a “buy” rating and a $81.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Endo International PLC in a research note on Tuesday, July 15th. They now have a $71.00 price target on the stock. Finally, analysts at Goldman Sachs upgraded shares of Endo International PLC from a “buy” rating to a “conviction-buy” rating in a research note on Monday, July 14th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Endo International PLC currently has an average rating of “Buy” and an average price target of $71.47.
Endo International PLC (NASDAQ:ENDP) traded up 1.64% during mid-day trading on Wednesday, hitting $67.75. 1,924,404 shares of the company’s stock traded hands. Endo International PLC has a 1-year low of $36.17 and a 1-year high of $82.16. The stock has a 50-day moving average of $68.46 and a 200-day moving average of $68.76. The company’s market cap is $10.316 billion.
Endo International PLC (NASDAQ:ENDP) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.92 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.84 by $0.08. The company had revenue of $595.00 million for the quarter, compared to the consensus estimate of $608.86 million. During the same quarter last year, the company posted $1.09 earnings per share. Endo International PLC’s revenue was down 9.3% compared to the same quarter last year. On average, analysts predict that Endo International PLC will post $3.75 earnings per share for the current fiscal year.
Endo International PLC, formerly Endo Health Solutions Inc, is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.